- $7.18bn
- $8.38bn
- $3.45bn
- 79
- 73
- 61
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,816 | 1,954 | 2,275 | 3,900 | 3,449 |
Cost of Revenue | |||||
Gross Profit | 2,461 | 1,562 | 1,934 | 3,265 | 2,860 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,371 | 3,317 | 2,031 | 2,313 | 2,407 |
Operating Profit | 445 | -1,362 | 245 | 1,587 | 1,042 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 203 | -1,549 | 42.9 | 1,450 | 921 |
Provision for Income Taxes | |||||
Net Income After Taxes | 172 | -1,255 | 48.8 | 1,141 | 725 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,150 | -1,149 | -73.7 | 965 | 662 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,150 | -1,149 | -73.7 | 965 | 662 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.594 | -2.05 | 0.586 | 6.3 | 4.56 |
Dividends per Share |